Professional Documents
Culture Documents
Boala Renala Diabetica: Rinichi Anatomie de
Boala Renala Diabetica: Rinichi Anatomie de
Spitalul Elias
UMF Carol Davlla
::-:::,.
--
-,_......... .
Clearance la creatinina
Creatfninaeste un produsfinal al metabolismulu
i
muscularexcretat exclusiv de rinichi.
musculara
Cocl<rolt-<iault
MORO
CKD-EPI
& MORO
CALCULATOR
EQUATION
4 vribt
ulng
Cl'(D-'BPI
at"drdhred
rum
~
...,
creUnln,
STUDV
- (Wlth
(Wtth
SI Unlts)
81 lJntt)
aa.
n1c,
g11:ndcr
redem.MO.rACP,rASN
,by:;,_,.,,.,..z
~\."IU
iS I
t!quNan
a,,.n ffocn,.,.,
<.!,.,.,:,.tlnt-...O
,,,.
I.
,-
.\.'l
~'
C- : ( : ,. r r; -..on,
f , - )'"V<III-,.
,.. A!'ri1. ,'Vl .,..,.,..
C. .,.
ll L1..al ~tr:iC:~S
, ..,,
""
,.
Al:
\'\rn.~,
1.
In generalsupraestimeazaRFG.
Prezentagreutatii in formula supraestimeazarezultatul in cazul
obezitatiisi prezenteiedemelor.
.,
-.,
"tt
.. ,1.. . ""'"'
" T ,tf".,
,..
,,,_.,.,
. ,, , ,.,
,,.,11r. 11, ,
., .. .,~~,.,.
_. ....,,,,.,.~
,..ra,,..,..
_,._ " '
.,,.r
,.
.,.,_..,.,.,,.
'r
111. ,., ..
http://www.kidney.org/professionals/kdoqi/gfr
_calculator.cfm
% cazuri
Diabet zaharat
44.9
Tipl
39
j;l:
:,~:rteosiuoe arteciala
Glomerulonefrita
8.2
3.6
3- .-1----
Neoplasme
2.1
Microalbuminuria (I)
Este rata persistent crescuta de eliminare urinara de
albumina (REA): 2 din 3 teste in 6 luni.
30-299 mg/24 h
20-199 microg/min (urina/24)
30-300 mg/g (RAC raport albumina/creatinina) din
esant1on oarecare de urina
Limita inferioara de 30 aleasa arbitrar
MORO
r;:;:~
-- -- ~y ...~r
!YJ:
F.?.a
ce
~ - Atri
.Q:ar 1t1er
~RACE
ln ;.,c,:etb l
Ai-nt'.>rl C a n
t)rtH)
<? AI I t~th
,r
I' ,) C.
I G!
.7 .3
.,...:.?
ln
)I'
http://www.kidney.org/professionals/kdoqi/gfr
_calculator.cfm
10/ :
In general supraestimeazaRFG.
Prezenta greutatii in formula supraestfmeazarezultatul ln cazul
obez1tatii si prezentei edemelor.
1
0/o
44.9
Diabet zaharat
Tip 1
Tip 2
l Hipertensiune
cazuri
3.9
41
arteriala
27.2
Normal
Colectare
ur1na/24h
Colectare
nocturna sau
2411
Raport urinar
NC (BarbaU)
Raportur1n.1r
NC(Fe~)
Prevalenta
OZ tlp 1 Intre 7-22%
OZtip 2 Intre 6-40%
Oupa 15 ani de evolutle 25-30% pentru ambeletipuri
>300 mg/21h
>200 IJQ{mlo
<25 mo/o
25300 mo/9
>300 moto
<30 mo/o
30-300 mo/o
>300 mofg
Mlcroalbuminune MIICTOaltxJmlnu
ne
Insuficientacardiaca
Ortostatismprelungit
Efort fizic Intens
Infectle urinara
Valori constantcrescuteale gllcemlel ln ultima perioada
Clintii OZ
H,;:,erfuoctle{
o-s, ..-
--
SllenOoS
-
OonlC
10-15"'"'
JJJ.IV
Insul'~
""4la V
- Nol'Id,pplnQ .
cAfG 60-90 mVmln
1s-2oan1
(macrnall>)
>20 eni
5-10 Ml
(I)
l nelplent
(mcclb) II
,~
MorfopatcloQIC
--
,.
H,pe,110lle
mezangtalll
Jng-.,1'.eG
--
roaJaJseo,nenwa
~g
HT.t.
; ESR.D
l.ezlont
SCleroatrollce
glomet\l.are
SI
UJWI<>
lntenUUale
Prcvillenta
Nr
padenU
1.78
milion
3.6
li
3.24
6.5
lll
Afectarerenalacu
scooeremoderilta
30-59
7.69
15.5
IV
Afeclllre "1\clla cu
1529
0.35
0.7
<15
0.25
0.5
lO<nervlale
<!duze
eRFG
mVmln/1.73ml
Sdero,a roduia!"I
M~l<TA
Stadiul Desaierc
Ne'rt>!a
!)lomenJ!omeQaUe
scadcresewns
V
Insu~nta renala
(ESRD)dlal<za
10/ 8/ 2015
Hiperglicemia
Endoteliu
O.stunctleendollala (este
al\m ta vasoo,latatla
~cn
ta oe nuxsi oeste
permeab4htatea
capo1araJ
excesde NO
Productie molecule blOoctN'e
(lnllamatle glomerulara )
Membranabazala
-.
eowm.n
Relt,,ua~a
P'!dlCelrler.
cea ma l
Mezanglul glomerular
, E,pansiune meianQl.)la
.Crtllklne pr0inflama\Or11
(TGF~)
Podocite
Managementul terapeutic
Obiective
lngrQSOre
Screeningpentru mtcroalbumlnurte
Incetlnlrea progresiei catre proteinurie
lncetlnlrea dec;Jinvlulfunctle! renale
Mentinerea optima a staril de nutritie
Controlulfactorilor de risc cardiovascular
Terapia de: substltutle a functlel renale
lrT\pOrW1UItwlera
~
ApoiXozapoclOOtelOr
Hiperglicemia
Endoteliu
......,~J.;~ -::.:_.-'.::: ..:.
Disfunctieendoteliala(este
alteratavasodilatatia
dependentade flux si creste
permeabilitateacapilara)
excesde NO
Productemoleculebioactive
(inflamatieglomerulara)
Membranabazala
f r:#,lif: .
ingrosare
(:(nt,~':".:4
. !l.i:18 , .
~~~t8"
Mezangiulglomerular
. . .
1~~~t.J\1P.l:\lg,.kc~:~
:~,l~
.> -.
Expansiunemezangiala
CitokineproinflamatorH
(TGF-~)
l;~, ;~,;
Podocite
SRAAhiperactiv:vasoconstrictiepe a. eferenta.
Managementul terapeutic
Obiective
Screeningpentru microalbuminurie
Incetinirea progresieicatre proteinurie
Incetinireadeclinului functiei renale
MPntin~r13r1 nntim~
epitelialacaredeHmiteaza
versantulurinaral Capsiuter
Bowman
Pedicele:prelungiri
digitiformeale p(:)dOCitelor
.
,i.
~
}'
Reteauatrid,imenstonalaa
pedicelelor:cea mai
importantabari.era
antiproteinurica
Apoptozapodocitetor
10/ 8/ 2015
1. Reducerea presiuniilntraglomerulare
2. Controlulmediului metabolic
Hemodiali
za: ceamaifrecventa
Dializa peritoneala
Transplant renal
Multumesc
~
-
--